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Lactococcin B (LcnB) is a small, hydrophobic, positively charged bacteriocin produced by Lactococcus lactis
subsp. cremoris 9B4. Purified LcnB has a bactericidal effect on sensitive L. lactis cells by dissipating the proton
motive force and causing leakage of intracellular substrates. The activity of LcnB depends on the reduced state
of the Cys-24 residue. Uptake and efflux studies of different solutes suggest that LcnB forms pores in the
cytoplasmic membrane of sensitive L. Iactis cells in the absence of a proton motive force. At low concentrations
of LcnB, efflux of those ions and amino acids which are taken up by proton motive force-driven systems was
observed. However, a 150-fold higher LcnB concentration was required for efflux of glutamate, previously
taken up via a unidirectional ATP-driven transport system. Strains carrying the genetic information for the
immunity protein against LcnB were not affected by LcnB. The proton motive force of immune cells was not
dissipated, and no leakage of intracellular substrates could be detected.
Lactic acid bacteria (LAB) are of eminent economic
importance because of their widespread use in food and feed
fermentations. Several LAB produce a number of different
substances with antimicrobial activity which are of potential
interest for food preservation. In a number of instances, the
inhibitory activity could be attributed to metabolic end
products such as hydrogen peroxide, diacetyl, and organic
acids (9). In addition, various LAB strains secrete protein-
aceous substances, usually of low molecular weight (bacte-
riocins), that are often active against closely related strains.
Bacteriocins of LAB can be divided into two subclasses:
(i) lantibiotics, small bacteriocins containing unusual amino
acids such as dehydroalanine, lanthionine, and 1-methyllan-
thionine (a well-known example is nisin [20], a 3.4-kDa
cationic peptide), and (ii) nonlantibiotics, a group of size-
variable bacteriocins (2.5 to 37 kDa) containing regular
amino acids (this group encompasses the lactococcins,
which are small [5- to 10-kDa] cationic peptides). In several
cases it has been demonstrated that bacteriocin production is
associated with plasmid DNA (1, 10, 13, 38), whereas in
other cases production was linked to chromosomal DNA
(22). In recent years, a large number of different bacteriocins
from LAB have been purified (2, 21, 31; for reviews, see
references 9, 25, 26, and 43) and some of the corresponding
genes have been cloned and sequenced (6, 46, 47; for a
review, see reference 26). However, the mode of action has
been described in detail for lactococcin A and nisin only (28,
34, 48).
The lactococcins belong to a broader group of antimicro-
bial cationic peptides (35) including some of completely
different origins: Pep5 from Staphylococcus aureus (27),
epidermin from Staphylococcus epidermidis (19), subtilin
from Bacillus subtilis (28), gallidermin from Staphylococcus
gallinarum (24), and the eukaryotic nonbacteriocin peptides
cecropins (8), alamethicin (16), melittin (17, 52), and magai-
* Corresponding author.
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nins (23, 53). In spite of their different sources, these
peptides have some properties in common, i.e., a molecular
mass of 3 to 6 kDa and a high isoelectric point. The peptides
also differ in certain aspects; some act voltage dependently
(3, 27, 36, 39), and others act voltage independently (48).
Some act on liposomes or planar lipid bilayers (8, 14, 15, 23,
52), whereas LcnA has no effect on liposomes and needs, in
all likelihood, a protein receptor for activity (48). However,
a common feature of these peptides seems to be their
capacity to form pores in the cytoplasmic membrane, the
pore channel being composed of several molecules of the
same peptide (8, 16, 37).
L. lactis subsp. cremors 9B4 produces at least three
bacteriocins, named lactococcins A, B, and M. The struc-
tural genes encoding the bacteriocins and their correspond-
ing immunity proteins are carried by plasmid p9B4 and have
been cloned and characterized (46, 47). lcnA from L. lactis
subsp. cremoris LMG2130 (18) and from L. lactis subsp.
lactis biovar diacetylactis WM4 (42) has also been cloned
and characterized. LcnA has been purified previously (18),
and its mode of action has been described elsewhere (48). An
active LcnM molecule consists of two complementary gene
TABLE 1. Bacterial strains and plasmids
Bacterial strain . Source orRelevant properties reeec
or plasmid reference
Bacteria
L. lactis subsp. Plasmid free, LcnBs 7
lactis IL1403
L. lactis subsp. LcnBs 41
cremoris SK112
Plasmids
pMB580 Emr pGKV210 derivative con- 47
taining the lactococcin B
operon (lcnB IciB)
pMB583 Emr pMB580 derivative con- 47
taining only the immunity
gene for lactococcin B
(IciB)
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FIG. 1. Effect of incubation with LcnB (1.7 x 102 AU/mg of protein) on the viability and optical density of L. lactis SK112 and L. lactis
SK112(pMB583). * and 0, SK112 viability and optical density, respectively; * and 0, SK112(pMB583) viability and optical density,
respectively. Counts of viable lactococcal cells are expressed as CFU per milliliter.
products (49). We purified LcnB (50) and report here its
effect on the membrane potential, pH gradient, and uptake
and efflux of amino acids in L. lactis cells.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The
bacterial strains and plasmids used in this study are listed in
Table 1. L. lactis strains were grown in M17 (44) broth
supplemented with 0.5% glucose (GM17) or in MRS (11)
broth containing 0.5% glucose at 30°C. Erythromycin was
used at a final concentration of S ,ug/ml unless indicated
otherwise.
Analytical methods. Protein concentrations were deter-
mined by the method of Bradford (5). Bovine serum albumin
was used as a standard.
Lactococcin B isolation. LcnB was purified from the super-
natant of L. lactis IL1403(pMB580) by ethanol precipitation
and preparative isoelectric focusing as described elsewhere
(50). The activity in the preparation was determined by serial
twofold dilution spot tests on a GM17 agar plate seeded with
the indicator strain L. lactis SK112 (50). The highest dilution
which gave a distinct zone of inhibition after 16 h was
defined as 1 arbitrary unit (AU). By this method a 0.4-ml
LcnB solution (106 AU/ml) was obtained from 1 liter of
culture.
Effect of lactococcin B on sensitive cells and immune cells.
Overnight cultures of L. lactis SK112 and L. lactis
SK112(pMB583), the strain carrying the gene for the immu-
nity protein for LcnB (IciB), were diluted to approximately
10 cells per ml in GM17. After addition of LcnB (1.7 x 102
AU/mg of cell protein), samples were taken at 30-min
intervals to determine (i) the viable cell count by plating onto
GM17 agar and (ii) the optical density at 660 nm.
Transport assays. Cells of strain L. lactis IL1403 grown
overnight in MRS broth were diluted 100-fold in fresh
medium and grown to an optical density at 600 nm of 0.6.
Cells were harvested by centrifugation, washed once with
KMES buffer [50 mM potassium 2-(N-morpholino)ethane-
sulfonic acid (MES), 50 mM KCl, and 2 mM MgSO4, pH
6.0], and resuspended in 1/50 of the original volume in
KMES buffer. Cells were stored on ice. Transport assays
were performed at 30°C. To 1.9 ml of KMES buffer contain-
ing 0.4% glucose as an energy source, 0.1 ml of cell suspen-
sion was added. Cell suspensions were incubated for 2 min.
Uptake was initiated by the addition of [1-14C]2-a-amino
isobutyric acid (AIB) (Amersham, Buckinghamshire, United
Kingdom) (59 mCi/mmol) or of L-[U-14C]glutamate (Amer-
sham) (285 mCi/mmol) to final concentrations of 8.5 and 1.75
,uM, respectively. Samples (0.1 ml) were taken from the
incubation mixture, diluted in 2 ml of 0.1 M LiCl to stop
uptake, and filtered with a 0.45-p,m-pore-size cellulose ni-
trate filter (Schleicher & Schuell, Dassel, Germany). Filters
were washed once with 2 ml of 0.1 M LiCl and air dried, and
the radioactivity was measured by liquid scintillation spec-
trometry in 2 ml of scintillator emulsifier 299 (Packard,
Downers Grove, Ill.) by using a Packard 460CD liquid
scintillation analyzer.
Measurement of the membrane potential. The change in
membrane potential of the cells was monitored by the
distribution of the lipophilic cation tetraphenylphosphonium
(TPP+) by using a TPP+-selective electrode (40). Cells were
washed and resuspended in KMES buffer as described
above. The incubation mixture was composed of 0.1 ml of
cell suspension and 1.9 ml of KMES buffer containing 0.4%
glucose and 4 ,uM TPP+. Upon addition of nigericin (1.0 ,uM)
(Sigma Chemical Co., St. Louis, Mo.), the interconversion
of the pH gradient resulted in an increase in the membrane
potential (12).
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FIG. 2. (A) Effect of LcnB (3.3 AU/mg of protein) on the membrane potential of energized cells of L. lactis IL1403. +, no addition; A,
addition of non-DTT-treated LcnB; *, addition of valinomycin (1 ,uM). (B) Effect of DTT (5 mM) on LcnB (3.3 AU/mg of protein) activity.
V, addition of DTT-treated LcnB; 0, addition of 5 mM DTT; *, addition of valinomycin (1 ,LM). (C) Effect of oxidation by HgCl2 (10 nM)
on LcnB (3.3 AU/mg of protein) activity. *, addition of HgCl2-treated LcnB; El, addition of HgCl2- and DTT-treated LcnB; V, addition of
DTT-treated LcnB. (D) Effect of DTT-treated LcnB (3.3 AU/mg of protein) on the membrane potential of energized cells of L. lactis subsp.
lactis IL1403(pMB583). The additions were made at the time indicated by the arrows.
Measurement of intracellular pH. Cells of L. lactis IL1403
and L. lactis IL1403(pMB583), grown in MRS broth, were
loaded with 2',7'-bis-(2-carboxyethyl)-5[and 6]-carboxyfluo-
rescein (BCECF; Molecular Probes, Inc., Eugene, Oreg.)
by using an acid shock as described elsewhere (29). For
both cell suspensions, 3 ,ul of 0.5 M HC1 gave optimal
loading. Cells were energized with 0.5% glucose. Fluores-
cence was measured as described previously (29) on a
Perkin-Elmer LS50 spectrofluorimeter with computer-con-
trolled data acquisition and storage. Experiments were done
at pH 6.0 and 30°C. Data were corrected for ATP-driven
efflux of the fluorescent probe (30).
RESULTS
Lactococcin B is bactericidal. To investigate whether the
mode of action of LcnB on sensitive cells was bactericidal,
bacteriostatic, or bacteriolytic, purified bacteriocin was
added to sensitive cells and the viable count and optical
density changes were determined as a function of time.
Strains L. lactis SK112 and L. lactis SK112 carrying the
immunity gene IciB on plasmid pMB583 were incubated with
LcnB (1.7 x 102 AU/mg of protein). Cells of strain L. lactis
SK112(pMB583) showed no growth inhibition or decrease in
viability. In contrast, 99% of the cells of the indicator strain
L. lactis SK112 treated with LcnB lost their colony-forming
ability after 1 h (Fig. 1). After 3 h of treatment only 0.001%
of the cells survived. However, prolonged incubation did not
result in further killing. The optical density of the treated
culture did not change during this experiment (Fig. 1). These
results indicate that LcnB acts bactericidally rather than
bacteriolytically on sensitive cells.
Reduced lactococcin B dissipates the membrane potential of
sensitive cells but not of immune cells. To examine whether
LcnB was capable of permeabilizing the cytoplasmic mem-
brane of sensitive cells, its effect on the membrane potential
was determined by monitoring the distribution of the li-
pophilic cation TPP+ in energized cells.
The results are presented in Fig. 2 and show that the
membrane potential of the sensitive L. lactis IL1403 cells
was dissipated by an LcnB concentration of 3.3 AU/mg of
protein. However, the rate of dissipation caused by the
VOL. 59, 1993
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FIG. 3. Effect of LcnB (6.7 AU/mg of protein) on the pH gradient of energized cells of L. lactis IL1403 (B) and L. lactis IL1403(pMB583)
(D). As a control, nigericin was added to cells of L. lactis IL1403 (A) and L. lactis IL1403(pMB583) (C). The additions were made at the times
indicated by the arrows. Abbreviations: gluc, glucose; val, valinomycin; nig, nigericin.
addition of 1 ,uM (final concentration) valinomycin, a K+
ionophore which dissipates the membrane potential if K+
ions are present, was much higher (Fig. 2A).
LcnB contains one cysteine residue at position 24 (47),
which might be oxidized during purification, thus affecting
the activity of LcnB. This possibility was examined by
comparing the effects of reduced and oxidized LcnB on the
membrane potential. LcnB was reduced by treatment with 5
mM dithiothreitol (DYT). Subsequently the effect on the
membrane potential of sensitive IL1403 cells by the DTT-
treated preparation was assayed. As shown in Fig. 2B, this
resulted in the dissipation of the membrane potential at a rate
similar to that observed after the addition of 1 ,uM valino-
mycin. As documented in the same figure, DTT alone had no
effect on the membrane potential. Treatment of LcnB with
DTT also increased the bactericidal activity of the bacterio-
cin; in a spot test the activity of LcnB increased twofold
after treatment with DTT (data not shown). Addition of
twice the amount of non-DTT-treated LcnB to the cells did
not increase the dissipation rate of the membrane potential in
a TPP+ experiment (data not shown). These results indicate
that LcnB activity requires the Cys-24 residue in a reduced
state. To corroborate this conclusion, the Cys-24 residue in
LcnB, fully activated by DTT treatment, was oxidized by
treatment with 10 nM HgCl2. The HgCl2-LcnB mixture was
added to sensitive L. lactis IL1403 cells. As shown in Fig.
2C, oxidized LcnB was not capable of dissipating the mem-
brane potential. Subsequent addition of DTT to the HgCI2-
LcnB mixture fully restored activity (Fig. 2C). Pretreatment
of sensitive cells with HgCl2 did not affect their sensitivity
towards LcnB (data not shown).
Strain L. lactis IL1403(pMB583) carries the IciB gene (42).
This gene codes for the immunity protein against LcnB. In
this strain the membrane potential did not dissipate after
addition of reduced LcnB (Fig. 2D), not even at concentra-
tions 100 times higher than those used for sensitive cells
(data not shown).
From these results we conclude that LcnB affects the
permeability of the cytoplasmic membrane of L. lactis
IL1403 for protons, thereby dissipating the membrane po-
tential, and that LcnB activity critically depends on the
reduced state of the Cys-24 residue. In strains carrying the
immunity protein, LcnB is inactive, even at high concentra-
tions.
Lactococcin B dissipates the pH gradient of sensitive cells
but not ofimmune cells. To examine the effect of LcnB on the
dissipation of the pH gradient, L. lactis IL1403 cells were
loaded with BCECF and diluted in 50 mM potassium-
phosphate buffer (KP buffer), pH 6.0, to build up a pH
gradient upon energization with 0.5% glucose (Fig. 3A).
Upon addition of 1 ,uM valinomycin, the interconversion of
the membrane potential resulted in an increase in the pH
APPL. ENVIRON. MICROBIOL.
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FIG. 4. Effect of LcnB on uptake and efflux of AIB in energized cells of L. lactis IL1403 (A) and L. lactis IL1403(pMB583) (B). Labeled
AIB was added at t = 0. At the time indicated by the arrows either valinomycin (1 ,uM) plus nigericin (1 jiM) (A) or reduced LcnB (6.7 AU/mg
of protein) (0) was added. No additions were made to the control (+). [ and V, AIB uptake after preincubation (3 min) with valinomycin
plus nigericin or with LcnB, respectively.
gradient. Upon addition of 1 ,uM nigericin, a K+/H+ iono-
phore, the pH gradient was dissipated and the pH of the
cytoplasm became equal to that of the KP buffer (Fig. 3A).
Reduced LcnB (6.7 AU/mg of protein) also dissipated the pH
gradient, at a rate similar to that caused by nigericin (Fig.
3B).
L. lactis IL1403(pMB583) cells were not affected by LcnB
(6.7 AU/mg of protein) (Fig. 3D). As expected, the pH
gradient was dissipated by nigericin (Fig. 3C and D). These
results indicate that LcnB dissipates the pH gradient in
energized sensitive L. lactis cells but not in immune cells.
Lactococcin B destroys the PMF. The results presented
above clearly demonstrate that LcnB causes a collapse of
both the membrane potential and the pH gradient in sensitive
cells but not in immune cells, indicating that LcnB makes the
membrane permeable for protons. The resulting collapse of
the proton motive force (PMF) should therefore also affect
PMF-dependent processes. To evaluate the effect of LcnB
on PMF-dependent amino acid transport, two sets of exper-
iments were carried out. The effects of reduced LcnB on (i)
the uptake of AIB (a nonmetabolizable analog of alanine
[45]) and (ii) the efflux of preaccumulated AIB were studied.
Figure 4A shows that, similar to the ionophore combination
valinomycin and nigericin (1 ,uM each), LcnB (at 6.7 AU/mg
of protein) blocked uptake of AIB and caused efflux of
preaccumulated AIB. Cells of strain IL1403(pMB583)
showed no leakage ofAIB at LcnB concentrations of 6.7 and
1,000 AU/mg of protein (Fig. 4B), whereas efflux did occur
upon addition of valinomycin and nigericin, as expected.
Lactococcin B induces pore formation in the cytoplasmic
membrane. To investigate whether LcnB also permeabilizes
the membrane for solutes larger than protons, use was made
of the fact that glutamate is taken up by L. lactis by a
unidirectional ATP-driven transport system (33). This sys-
tem is further characterized by being active in the absence of
a PMF in cells kept at an alkaline pH but by being inactive in
cells at pH 6.0. At the latter pH the ATP-driven transport
system can function only in the presence of a pH gradient.
However, because the uptake system is unidirectional, efflux
of glutamate is PMF independent. Figure 5A shows that
preincubation of L. lactis IL1403 cells at pH 6.0 with LcnB
completely blocked uptake of glutamate, which is in agree-
ment with the observation that the pH gradient is dissipated
by LcnB (see previous section).
Addition of LcnB at a concentration of 6.7 AU/mg of
protein had, similar to valinomycin and nigericin, no effect
on efflux of glutamate. However, addition of LcnB at a 150
times higher concentration (1,000 AU/mg of protein) caused
efflux of glutamate (Fig. 5A). In contrast, no efflux of
glutamate was observed in L. lactis IL1403(pMB583), not
even at this high a concentration of LcnB. These results
indicate that at high concentrations of LcnB the cytoplasmic
membrane of L. lactis IL1403 becomes permeable for sol-
utes as large as glutamate.
Several bacteriocins have been described as having a
voltage-dependent pore-forming ability (32, 36, 39), whereas
LcnA increases the permeability of the cytoplasmic mem-
brane in a manner independent of the PMF (48). To investi-
gate the PMF dependency of LcnB, cells of strain L. lactis
IL1403 were allowed to accumulate glutamate. Subse-
quently, the preloaded cells were treated with the uncou-
plers valinomycin and nigericin to dissipate the membrane
potential and the pH gradient, after which LcnB was added.
As documented in Fig. 5A, a high concentration of LcnB
(1,000 AU/mg of protein) caused efflux of glutamate in the
VOL. 59, 1993
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FIG. 5. Effect of LcnB on uptake and effiux of glutamate in energized cells of L. lactis IL1403 (A) and L. lactis IL1403(pMB583) (B).
Labeled glutamate was added at t = 0. At the time indicated by the arrows either valinomycin (1 ,uM) plus nigericin (1 puM) (A) or reduced
LcnB (1,000 AU/mg of protein) (0) was added. No additions were made to the control (+). K, addition of first valinomycin plus nigericin
followed by LcnB; O and V, glutamate uptake after preincubation (3 min) with valinomycin plus nigericin or with LcnB, respectively.
absence of a PMF. This result suggests that LcnB is active in
the absence of a PMF.
DISCUSSION
LcnB is one of the three bacteriocins produced by L. lactis
subsp. cremoris 9B4. In this work we determined the effect
of LcnB on cell viability and lysis of cell cultures of a
sensitive strain. Furthermore, we investigated the influence
of LcnB on sensitive and immune cells with respect to the
membrane potential, pH gradient, and amino acid uptake
and efflux.
Apparently the activity of LcnB is bactericidal, causing a
decrease in CFU of a sensitive culture of over 99% in 3 h.
LcnB causes an increase in membrane permeability in the
absence of a membrane potential, similar to LcnA (48).
However, LcnB differs from LcnA with respect to its
requirement for a reducing environment for activity. It is
conceivable that the reduced state of the Cys-24 residue, the
only cysteine present in the molecule, is uniquely required
for receptor recognition. Alternatively, the oxidized state of
Cys-24 may affect the structure of the bacteriocin in such a
way that it is unable to insert itself in the membrane or is
unable to participate in pore formation. In this regard LcnB
would resemble a group of thiol-activated toxins (4) in which
the reduced state of the cysteine residue appears to be
essential for the generation of functional lesions in toxin-
treated membranes (4).
The bactericidal effect of LcnB on sensitive L. lactis cells
appears to be due to dissipation of the membrane potential
and pH gradient caused by leakage of ions. At low concen-
trations of LcnB, efflux of AIB from sensitive cells occurs;
only in the presence of a high concentration of LcnB (1,000
AU/mg of protein) was glutamate efflux from sensitive cells
observed. The requirement for a high concentration of the
bacteriocin to allow the passage of glutamate may be ex-
plained on the basis of the assumption that several LcnB
molecules form a multipeptide complex with an internal
channel through which low-molecular-weight solutes such as
ions and amino acids flow. Apparently LcnB forms these
pores in a PMF-independent manner, since depolarization of
the membrane with valinomycin and nigericin prior to addi-
tion of LcnB does not influence the effect of LcnB on the
efflux of glutamate. The quantity of LcnB added in this
experiment (1,000 AU/mg of protein) corresponds to approx-
imately 1.3 x 104 molecules per cell. A twofold reduction in
added LcnB (500 AU/mg of protein or 6.6 x 103 molecules
per cell) did not affect the efflux of accumulated glutamate
(data not shown). However, at this and lower concentrations
(6.7 AU/mg of protein or 88 molecules per cell), efflux of ions
and AIB was observed. This suggests that at low concentra-
tions a multipeptide complex of LcnB molecules forms a
pore which is too narrow for the passage of amino acids but
allows the passage of protons and possibly other small
solutes.
Liposomes are insensitive to lactococcins (48), including
LcnB (51), suggesting that for the action of lactococcins a
membrane-associated receptor protein is necessary.
The present results clearly indicate that cells carrying the
immunity gene IciB are insensitive to LcnB. The immunity
proteins are probably located in the cytoplasmic membrane,
since vesicles derived from immune cells are also immune to
the action of the bacteriocin LcnA (48). Several possibilities
can be entertained to explain the insensitivity of immune
cells to the action of the bacteriocin: (i) the immunity protein
shields the receptor protein, such that the bacteriocin cannot
APPL. ENVIRON. MICROBIOL.
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recognize its target, (ii) the immunity protein interacts with
the bacteriocin, such that the bacteriocin molecules are
unable to form a pore in the membrane, or (iii) the immunity
protein closes the pores formed by the bacteriocin mole-
cules. In all of these possible mechanisms to explain immu-
nity it might be expected that an excess of bacteriocin
molecules over immunity protein molecules would result in
breakdown of immunity, which actually has been shown to
be the case for LcnA (48).
An important finding of this study is that bacteriocins can
apparently exist in an oxidized, inactive state. In view of this
conclusion, it is recommended that screening programs of
antimicrobial agents assay possible candidates under aerobic
as well as under anaerobic conditions, because otherwise
interesting bacteriocins might escape detection.
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